Thursday, 30 November 2017

Two New Studies Confirm, Again, That Cannabis Reduces Opioid Use

This time the data comes from Illinois and New Mexico.



by Randy Robinson

Two new independent studies indicate that medical cannabis programs can significantly curb opioid use for controlling pain.

The first study, published in the journal PLOS One, was conducted by researchers at the University of New Mexico, who looked at 37 patients with chronic pain enrolled in New Mexico’s medical cannabis program and tracked them over a 21 month period. A final survey of the patient pool found that over 80 percent of respondents significantly reduced their opioid use with the aid of cannabis; roughly 40 percent of the patients studied ceased all opioid use in favor of weed.

The second study comes from a private research firm in Illinois, Aclara. Although the Illinois study won’t be finalized until early next year, their preliminary data agrees with findings from previous opioid and cannabis studies. A press release published Tuesday stated that out of 400 patients in Illinois, 67 percent stopped taking all opioid drugs after enrollment in the state’s medical marijuana program; 37 percent stopped using all conventional prescription medications; and over 60 percent of respondents said they not only reduced their use of prescription drugs, but also took fewer trips to the pharmacy once they got on medical marijuana.

Pharmacists themselves had something to say, too. The Aclara study also surveyed 500 Illinois pharmacists, and found that 87 percent of them agreed that cannabis should be legal for medical use, while 69 percent said they should be allowed to dispense cannabis products through pharmacies.

“Patients are using cannabis, successfully, to wean themselves off opioid usage,” says Carmen Brace, the founder of Aclara Research. “The results within this study, that 67 percent of patients stopped taking opioids, are also consistent with a Journal of Pain article from 2016.” That study found a 64 percent reduction in opioid use among medical cannabis patients reporting chronic pain. Last month, another study from DePaul and Rush universities drew similar conclusions about Illinois’ medical marijuana patients.

According to STAT, 100 Americans die per day from opioid overdoses. At the current rate, over half a million Americans could die from opioid abuse over the next decade.

One of the most eye-opening studies came last year from the Johns Hopkins Bloomberg School of Public Health. The 2016 analysis found that states with medical marijuana programs, overall, saw 25 percent less opioid-related deaths compared to states without them.

“All retroactive studies indicate very similar results,” Brace continues. “I think, as more and more of us publish this type of research, within the confines we’re relegated to with the Schedule I designation of this plant, it’s really just increased the body of research to review this [plant’s ability] to resolve a national crisis.”

In August, President Donald Trump declared the opioid epidemic a national emergency, while U.S. Attorney General Jeff Sessions has insisted that cannabis is a “gateway drug” that has worsened the opioid crisis — contrary to a snowballing quantity of medical and scientific evidence.

Elizabeth Warren Writes Letter To Trump Administration Urging It To Look Into Marijuana As An Opioid Alternative

By Joseph Misulonas

The Trump administration has made tackling America's opioid crisis a priority, However, they've refused to acknowledge that marijuana can be a safer alternative to opioids despite significant scientific evidence and data suggesting that it's true. But now one senator is stepping up and calling out the administration on the issue.

Senator Elizabeth Warren, a Democrat from Massachusetts, wrote a letter to President Trump's nominee to run the Department of Health and Human Services, Alex Azar, about the possibility of using marijuana as an alternative to opioids. Warren cited studies showing that states with medical marijuana experience less opioid abuse and another showing that prescription painkiller overdoses decreased in Colorado after cannabis legalization.

"Medical marijuana has the potential to mitigate the effects of the opioid crisis," Warren wrote. And she said the results of these studies are "consistent with other data from states that have developed laws for medical or recreational marijuana use."

Warren then asked Azar three questions in the letter: 
1. As HHS Secretary, what would you do to further study this potential alternative to opioids?
2. Are you committed to implementing evidence-based policies regarding its use?
3. What steps will you take to improve our knowledge of the potential therapeutic benefits of marijuana when used for medical purposes?
An anti-opioid commission created by Trump recently put out a statement saying that marijuana is not a viable alternative, despite this scientific evidence and data. Azar's opinion on medical marijuana has not been made clear, but considering that the rest of Trump's administration seems to be strongly against it, there's a pretty good chance he is as well. He's also a former pharmaceutical executive, so his background would suggest that position as well.

Trump and Warren have often butted heads since his candidacy last year. The two frequently go at each other on social media, with Trump often referring to the senator as "Pocahontas" due to her claims of Native American ancestry. Many believe Warren will run for president in 2020, so the issue of opioids and marijuana could wind up being an election issue if that's the case.

Will you be able to grow weed at home? Here's what we know about the N.J. pot bill

Constitutional Court says Marijuana usage is not criminal offence

by the Constitutional Court of Georgia.  

Georgia’s Constitutional Court has revealed a verdict today, saying that no one will be sent to prison for using marijuana.


The same court decriminalized the use of the drug in 2015, but the solution only concerned up to 70gr dried cannabis.


 In September 2016 the court also banned imprisonment for repeated use of up to 70gr marijuana.


In today’s ruling the court gave no certain amount of drugs which could be only of personal usage and stated that using the drug without a doctor’s prescription, for recreational purposes, must not be a criminal offence.


However, the verdict does not remove the fine and the administrative punishment for using the drug.


The ruling does not also concern the purchase and sale of drugs which still remain a criminal offence.


The author of the legal suit was a Georgian citizen Givi Shanidze, whose interests were protected by the political party Girchi member Iago Khvichia.


The man demanded the removal of the 273th article of the criminal code which envisages punishment for marijuana usage without a doctor’s prescription.


 Before October 2015, Georgia’s laws on marijuana allowed a person to be jailed for seven to 14 years if he or she was found with a large amount of marijuana. The same law determined 50-500g of marijuana as "a large amount”.

Cannabis or alcohol? Science reveals which is the most dangerous

Are you surprised by the results?

By
Science has finally revealed which is more harmful to your health out of cannabis and alcohol.

There are dozens of factors to account for, including how the substances affect your heart, brain, and behaviour, and how likely you are to get hooked.

A comprehensive round-up of studies by the team over at IFLScience appears to show that cannabis really isn't as bad for you as alcohol is, Cornwall Live reports.

Alcohol has been found to be more addictive than cannabis
More than 30,700 Americans died from alcohol-induced causes in 2014 - not including drinking-related accidents or homicides - while there have been zero documented deaths from marijuana use alone.
 
According to the World Health Organisation, booze is thought to contribute to 3.3 million deaths across the globe each year which, soberingly, equates to one person dying every 10 seconds.

Yet the comparison is slightly unfair; while scientists have been researching the effects of alcohol for decades, the science of cannabis is a lot murkier because of its mostly illegal status.

A bottle of vodka
A bottle of vodka
Addiction, cancer risk, mental illness and weight gain are just some of the factors which users must consider before taking either alcohol or marijuana. So what makes alcohol worse for you than weed?
 

Addiction - ALCOHOL
Marijuana appears to be significantly less addictive than alcohol. A study of the drug habits of 8,000 Americans revealed that 15% could be classed as addicted to alcohol, while 9% were addicted to weed.

Cancer risk - ALCOHOL
Alcohol is strongly linked with several types of cancer; marijuana is not. We know about the links between alcohol and mouth or liver cancer. For marijuana, some research initially suggested a link between smoking and lung cancer, but that has been debunked.

Do you know the risks associated with cannabis?
Do you know the risks associated with cannabis?
Affect on memory - BOTH
Both drugs negatively affect your memory — but in different ways. These effects are the most common in heavy, frequent, or binge users.

Mental illness - BOTH
Both drugs are linked with an increased risk of psychiatric disease. For weed users, psychosis and schizophrenia are the main concern; with booze, it's depression and anxiety.

The largest review of marijuana studies found substantial evidence of an increased risk among frequent marijuana users of developing schizophrenia — something that studies have shown is a particular concern for people already at risk.

Drink lands a lot of people in trouble
Weight gain - ALCOHOL
Weed gives you the munchies, but despite eating over 600 extra calories when smoking, marijuana users generally don't have higher body-mass indexes. In fact, studies suggest that regular smokers have a slightly reduced risk of obesity.

Alcohol, on the other hand, appears to be linked with weight gain. A study published in the American Journal of Preventative Medicine found that people who drank heavily had a higher risk of becoming overweight or obese. Plus, alcohol itself is caloric: A can of beer has roughly 150 calories, and a glass of wine has about 120.

Conclusion: All things considered, alcohol's effects seem markedly more extreme — and riskier — than marijuana's
When it comes to addiction profiles and risk of death or overdose combined with ties to cancer, car crashes, violence, and obesity, the research suggests that marijuana may be less of a health risk than alcohol.

Still, because of marijuana's largely illegal status, long-term studies on all its health effects have been limited — meaning more research is needed.

It depends on your definition of "dangerous" as to which is worse.

I used to work with some pot smokers. I saw bright and intelligent useful members of a small team become unreliable, couldn't-care-less, wasters in a very short space of time. They were irredeemable.

Don't believe anyone who says pot is harmless.

Tuesday, 28 November 2017

Study Finds Cannabis Use May Benefit Heart Failure Patients

Joanne Cachapero
 
 
 
In an unpublished study presented at the American Heart Association’s Scientific Sessions meeting in Anaheim, California, held this month, researchers found a possible link between cannabis use and decreased risk for arterial fibrillation in patients with heart failure.

Additionally, death rates for cannabis-using hospitalized heart failure patients were lower than for those who did not use cannabis, said LiveScience.com.

Researchers did not recommend cannabis use and said that further research on the effects of cannabis use on patients with heart disease is needed. Lead study author Dr. Oluwole Adegbala said the results of the study were surprising because researchers hypothesized the opposite conclusion, or that cannabis use would result in greater risks for heart failure patients.

Researchers analyzed patient database information for six million heart failure patients hospitalized between 2007 and 2014. Of those six million, little more than 24,000 patients admitted marijuana use, with 1,200 of those reporting chronic use of cannabis.

Study results showed that occasional cannabis users were 18 percent were less likely to experience arterial fibrillation, and the same was true for 31 percent of patients that used cannabis regularly.

The study found also that 46 percent of nondependent cannabis-using heart failure patients were less likely to die in the hospital, while among those patients that used cannabis regularly, 58 percent were less likely to die while hospitalized.

Dr. Adegbala theorized that cannabinoids in marijuana may help alleviate inflammation, an important risk factor for arterial fibrillation, but said that more research was needed. By analyzing only data, researchers were unable to say whether other factors, like cigarette smoking, diet, among others, may have also affected patient outcomes.

Medical Marijuana Could Reduce Opioid Use: New Mexico Scientists

The University of New Mexico researchers recently published their findings in the journal PLOS ONE.

By Associated Press,

Medical Marijuana Could Reduce Opioid Use: New Mexico Scientists
ALBUQUERQUE, NM — The lawful availability of medical marijuana could reduce opioid use among chronic pain patients, University of New Mexico researchers said in research recently published in the journal PLOS ONE.

The work of associate psychology professor Jacob Miguel Vigil and assistant economics professor Sarah See Stith indicated there was a strong correlation between enrollment in the state's medical pot program and cessation or reduction of opioid use.

A significant proportion of patients substituted cannabis for their opioid prescriptions, informal surveys showed according to Vigil. The study tracked 37 habitual opioid using, chronic pain patients who enrolled in the state medical marijuana program between 2010 and 2015, compared to 29 patients with similar health conditions who didn't enroll.

As of October, more than 44,000 people were enrolled in the state program.

'Consequence Strains' ad campaign aims to keep drivers who are high on cannabis off the road

Bizarre ad campaign makes up different cannabis strains named after consequences of drug-impaired driving

by Amanda Siebert

With legal cannabis on the horizon, it seems politicians, parents, and law enforcement are more concerned than ever with drug-impaired driving.

One advertising agency is highlighting that concern with a marketing campaign that turns cannabis itself into a warning against driving while high.

In a campaign created by BBDO Toronto, road safety group Reduce Impaired Driving Everywhere (R.I.D.E) has collaborated with Hamilton, Ontario-based licensed producer Beleave to create three new strains of cannabis that warn users about the dangers of getting behind the wheel while under the influence of cannabis.

These aptly named "consequence strains" include Kourtroom Kush, Slammer Time, and White Whiplash. Each promises a distinctly unique experience.

According to ConsequenceStrains.com, Kourtroom Kush, an indica, "is an emotional joyride that doesn't end well. This first-time offender conjures up feelings of regret, shame and guilt. The same emotions as someone who's just been charged with impaired driving” (in case you had any doubts).

White Whiplash, on the other hand, is a hybrid, and apparently, "starts mellow then hits you hard."

"This bitter bud has been known to strike the perfect balance of misery and devastation. A similar outcome to someone suffering form the pain of an auto accident injury." Talk about flower appeal.

Slammer Time, a sativa, "packs a potent punch, often inducing feelings of remorse, paranoia and isolation from the outside world. The same feelings as someone who's been sentenced to life in prison for killing another driver or pedestrian."

Each strain is meant to illustrate a possible consequence of driving while high: Getting caught and being charged with a DUI, getting into an accident and suffering from life-changing injuries, or killing another person and spending the rest of your life in prison.

While these strains won't actually be available for purchase—as if any self-respecting cannabis consumer would be interested in "feelings of regret, shame and guilt"— posters depicting flowers and warnings will be made available for display purposes in Canadian cannabis dispensaries.

In an interview with AdweekBBDO Toronto creative chief Denise Rosesetto said that while the agency did want the campaign to be "very anti-driving-while-impaired", they didn't want to convey an anti-cannabis message.

A video associated with the campaign sheds light on the fact that some cannabis consumers believe they can drive under the influence without being impaired. It quotes users who say that they're "more focused" when stoned, and that it's "not a problem" for them to drive after a puff.

“I think there’s a public perception that marijuana, because it’s a sort of natural product, that it doesn’t have the same sorts of negative effects associated with alcohol use while driving. That is a dangerous perception,” says neuroscientist Dr. Steven Laviolette in the video.

It goes on to claims that 500,000 Canadians have admitted to driving under the influence of cannabis in the past year, and predicts that the number will only grow after cannabis is legalized.

Jenna Valleriani, a drug policy researcher at the University of Toronto, told the Straight in a telephone interview that the campaign’s use of fear tactics only serves to exaggerate the concerns that Canadians already have about cannabis and driving.

“Driving absolutely is one of the major public health concerns with legalization, but it [the campaign] is playing into this Reefer Madness idea that the only way to get people to not drive while is high is to scare them out of it,” she said. "They've really missed the mark."

She said that the prevalence of cannabis users who consume and drive “underscores the need for education around the implications of driving while high, not for more scare tactics or more moralizing language."

And while Dr. Laviolette says it's dangerous to assume that cannabis can't impair like alcohol can, Valleriani says it's also not accurate to put alcohol and cannabis on the same playing field.

Beyond the fact that the message of the campaign won’t resonate with the experiences of people who already say they’re driving under the influence, Valleriani is also concerned that the campaign’s message will further stigmatize cannabis use.

“For people who aren’t cannabis users, or who are looking from the outside in, this kind of fuels their fears around cannabis and driving,” she added.

“We should be moving to ward norms around how to appropriately use cannabis in a legalized context, not playing off of the same types of strategies that we’ve used for years that have proven to be ineffective.”

Monday, 27 November 2017

Can CBD get you high, and other questions about the legality of CBD in Indiana

Kaitlin L Lange

Attorney General Curtis Hill deemed cannabidiol oil illegal under Indiana law, in an official opinion Tuesday. 

The announcement followed months of confusion from state law enforcement agencies over the legality of the product. 

Here's what you need to know about CBD and Indiana laws surrounding it:

What is Cannabidiol?

Cannabidiol oil, or CBD oil, is a cannabis extract, typically used for health purposes.

In most cases, and under Indiana law, CBD refers to the extract that comes from hemp plants, a cannabis plant containing less than .3 percent tetrahydrocannabinol  (THC). 

However, typically if the CBD oil used for health purposes comes from a marijuana plant with higher levels of THC, it's deemed medical marijuana.

Can it get you high?

Nope. THC is the chemical that produces a high in marijuana. Hemp-derived CBD only has trace amounts of THC. 

"You could smoke an acre of industrial hemp and you could have a really bad headache before you got high," said Jenna Beckerman, a botanist and plant pathologist at Purdue University.

Is it legal in Indiana?

If it contains more than .3 percent THC, it's illegal in Indiana. That's where the agreement stops.

Attorney Genral Curtis Hill says CBD is illegal, regardless of how much THC is in the product.

During the last legislative session, Gov. Eric Holcomb signed a bill that created a registry for patients with treatment-resistant epilepsy who want to use CBD. Those on both sides of the CBD legality debate agree: the product is legal for those on the registry. 

A separate 2014 Indiana law created licenses for researchers to grow industrial hemp, defined as containing less than .3 percent THC. The 2014 bill noted that industrial hemp would thereafter be excluded from the definition of marijuana.

But in Hill's official opinion, he states that the use of the 2014 bill was only intended for limited purposes. 

"Simply put, cannabidiol is a schedule 1 controlled substance because marijuana is a schedule 1 controlled substance," Hill said in his written advisory opinion. 

Some in the CBD industry still say it's legal, and plan to fight any law enforcement who try to shut operations down.

So will I get arrested for using it?

For now, whether or not someone gets prosecuted for having CBD oil could depend on the agency. 

While Hill's opinion doesn't have the force of law, it can be used as a guide for officials trying to sort out the state of current law.

Individual police departments and prosecutors can choose whether to charge anyone for possessing or selling CBD oil. 

Stephanie Wilson, a spokeswoman for Holcomb, said he has asked his legal team to "review the opinion for potential impact on state agency operations."

Other police departments and prosecutors can make their own decisions. 

This summer, the Indiana State Excise Police confiscated products at nearly 60 stores, before questions arose about the legality of the busts and CBD. The agency didn't say whether the busts would restart now that Hill's opinion has been released. 

Does the federal government consider it illegal?

The Drug Enforcement Agency released a statement saying it views the product as illegal, except when it's grown by universities or state departments of agriculture under the 2014 Farm Bill.

The DEA also considers marijuana illegal, but the federal government hasn't cracked down on any states that have legalized the product.

CBD oil touted as broadly beneficial, but still potentially illegal

CATHY MCKITRICK
A quick internet search yields scores of websites touting cannabidiol or CBD oil as an aid to relieve pain and anxiety, minimize epileptic seizures, protect brain neurons, halt cancer growth, treat acne and more. But reaping benefits can still be prosecuted as a crime, even when Tetrahydrocannabinol or THC — marijuana’s psychoactive component — is absent.

Layton resident Colette Hadlock said she uses the non-THC CBD oil as an all-purpose pain reliever and stress reducer,  “so I can think more normally, be happier, kinder and more organized.”

“It makes my system function better to help my body heal,” Hadlock said of the enhanced well-being she attributes to the oil’s use.

Hemp is a form of cannabis with little or no THC. And for some, its use can be life-altering.

Doug Rice of West Jordan credits CBD oil for giving him more quality time with his daughter, who began to suffer epileptic seizures in her teens. Rice serves as a board member of TRUCE Utah (TRUCE stands for Together for Responsible Use and Cannabis Education) and vice-president of the Epilepsy Association of Utah.

“For Ashley, it reduces the severity and duration of her seizures,” Rice said.

Before Utah lawmakers passed the narrowly tailored Charlee’s Law in 2014, Ashley suffered one to two dozen seizures per day, some lasting two minutes or longer. But Charlee’s Law allowed Rice to get a hemp extract registration card so Ashley could try the non-THC CBD oil. And that usage actually halted her seizures for awhile.

“Now (in her mid-20s) she’s up to three or four per day that each last 30 to 90 seconds,” Rice said.  “And each seizure affects brain tissue, causing damage.”

Rice said Ashley now fares better with THC as part of her CBD oil regimen. “If we add to 2 to 5 milligrams of THC to 25 milligrams of CBD twice per day, we see seizures drop to total control or only one per day,” Rice said. Products containing THC can be purchased legally from dispensaries in Colorado, so excursions to the nearby state gave his family the opportunity to test their effects.

“We’re a lot more active now,” Rice said, pointing to a recent three-week motorcycle trip he took with his wife and daughter across the U.S. “We pretty much have our child back. She’d now give you a hug and kiss — but under pharmaceuticals she was a zombie. She sat there in a catatonic state ... the child we see now is happier, healthier and more robust.”

Legal roadblocks
Since passage of the Controlled Substance Act in 1970, the federal Drug Enforcement Agency has classified cannabis as a Schedule I illicit drug alongside heroin, LSD and ecstasy. And marijuana still ranks a notch above highly addictive Schedule II pharmaceuticals that include Vicodin, Dilaudid, Demerol, OxyContin and fentanyl.

But as awareness and demand for the plant’s benefits spread, states began legalizing cannabis for medical or recreational use — or both. According to governing.com, 29 states and the District of Columbia have such laws on the books. And in California, adults 21 and older can grow up to six plants in their homes.

Ogden based company CBD Infusions sells CBD oil at local smoke shops and online. The product is made with cannabinoids from hemp, but doesn't contain any active THC. Certain CBD oils are legal in Utah for limited uses.
Ogden based company CBD Infusions sells CBD oil at local smoke shops and online. The product is made with cannabinoids from hemp, but doesn't contain any active THC. Certain CBD oils are legal in Utah for limited uses.
In spite of a robust public push to legalize medical marijuana here in Utah, lawmakers voted against it. Now, citizens organized as the Utah Patients Coalition have taken the matter into their own hands in hopes of putting a detailed ballot initiative to voters in November 2018.

The passage of House Bill 105 or Charlee’s Law in 2014 allowed patients with epilepsy to purchase registration cards so they could possess CBD oil with less than .3 percent THC without fear of prosecution. But in hindsight, the legislation fell woefully short in addressing the broader need for medical cannabis.

“HB105 started from a group of Utah County moms and families across the state that were dealing with epileptic children and their seizures,” said Rep. Gage Froerer, a Huntsville Republican who served as the bill’s main sponsor. “Some of the families had used Charlotte’s Web (produced in Colorado) and found it to be effective in reducing the number of seizures for their children. But under state and federal law they could still be pulled over and thrown in jail because hemp federally is still illegal.”

But Charlee’s Law signaled the start to the medical marijuana discussion here in Utah, Froerer said.

Rice currently buys Charlotte’s Web, an artisan hemp extract oil manufactured by the Stanley Brothers in Colorado. He said he pays $275 for a 100 milliliter bottle that provides 5,000 milligrams of CBD and lasts about 90 days. Less concentrated and less expensive CBD oils can be purchased in local health food stores and smoke shops, but some of those contain only 75 to 125 milligrams of CBD, Rice said, and are mixed with a carrier oil such as coconut or olive.

Heather Jackson was instrumental in the passage of Charlee’s Law. Her son Zaki is now 14 and was one of the first patients to benefit from Charlotte’s Web.

“My son started using CBD products a little over five years ago, and he was receiving hospice prior to that,” Jackson said. “His condition went into remission right around three months of use back in 2012, and I realized the need to formalize an organization that could help families and physicians access this as a means of therapy.”

Her Colorado nonprofit, Realm of Caring, now tracks more than 40,000 patients around the globe and partners with major research institutions to collect information about the impact of cannabis therapies.

“It’s how I make sense of a decade of trying to keep my kid alive. I have a great respect for families who are out of options and doing all they can to help their children,” Jackson said. Her one regret is not discovering CBD oil sooner. “What if we had found this early on and avoided those years of suffering,” she said. But she quickly moves on, because many families need her help.

Survey says
On Wednesday, Nov. 15, preliminary survey results from registration card holders were presented to the Health and Human Services Interim Committee on Utah’s Capitol Hill.

Since July 2014, a total of 231 annual registration cards have been issued — 134 to patients under 18, and 97 to patients 18 and over.  At the end of this October, 119 patients still hold active cards.

The 12-question survey, compiled by the University of Utah’s Division of Pediatric Neurology, was sent to 139 patients who registered for cards between July 2014 and October 2016. Of that number, 46 responded and 41 had started taking hemp extract. Of that 41, 20 were under 18 and 21 were 18 and older.

Of that group of 41, 22 percent of respondents under 18 reported that their seizures were almost completely controlled and 40 percent said seizure severity was also “quite a bit better.”

Conversely, among respondents 18 and older, 22 percent reported no reduction in seizure frequency and 40 percent said seizure severity showed no improvement.

But overall, 85 percent of respondents under 18 and 56 percent of adult respondents reported some improvement in seizure frequency and severity.

Only nine reported adverse effects (fatigue, diarrhea, moodiness, coordination problems and either increased or decreased appetite), while 27 cited benefits such as improved sleep, improved speech, and being happier, more alert and more social.

When asked if there could have been a better way to gather the data, Dr. Francis Filloux, U of U’s Pediatric Neurology Division chief, said they were constrained by federal HIPAA rules and lacked permission to contact participating families. But Epidiolex, a CBD product manufactured by GW Pharmaceuticals, is currently undergoing clinical trials here in the U.S.

Annette Maughan, former president of the Epilepsy Association of Utah, said her son Glenn participated in an Epidiolex study at the University of Utah after Charlee’s Law passed.

“Our little results showed better than 50 percent response and 50 precent reduction in seizures,” Maughan said. “Our boy showed 80 percent reduction, and his congiitive improvement has beeen substantial.”

Maughan — who recently moved to Maryland — regrets the limited reach of Charlee’s Law, but said that was the only way proponents could get the measure to pass.

“We did try to get it for more people when we were lobbying for Charlee’s Law, to make it more available for more conditions,” Maughan said. “But we were told to limit to epilepsy or they’d kill the bill.”

But now she fully supports Utah’s drive to legalize medical cannabis and would like to see approval of 1:1 ratios of THC to CBD.

“I’m absolutely a strong supporter of a fully codified medical marijuana program. But you can’t just say that anyone can manufacture it and provide it to the public,” Maughan said.

Is hemp extract legal?
It all depends on whom you ask. In 2014 the U.S. Congress passed the Farm Bill which allowed a state Department of Agriculture to grow industrial hemp with up to .3 percent THC for the purpose of conducting research. But Utah has yet to jump on that bandwagon.

“Utah is in a prime moment in time to lead out on this, and they’re missing it,” Maughan said, noting that Utah State University had been willing to conduct that research but the state’s Department of Agriculture has yet to set up the hemp cultivation program.

In February, the nonprofit Brookings Institution weighed in on CBD and federal law, stating that even with the 2014 Farm Bill, its strict rules about how hemp can be grown in the U.S. outlaw cultivation for commercial purposes. Brookings concluded “one thing is clear: in order for a truly CBD-only product to be declared legal, other laws would need to be amended.”

But CBD-only manufacturers see enough ambiguity in the law to continue their work. Ogden resident Ken Barnes owns and operates CBD Infusions, selling a THC-free tincture available online at www.cbd-infusions.com or for in-person purchase at Gourmet Vapor, 1167 W 12th St. #3, in Ogden.

As a disabled Veteran who served in the Middle East, Barnes said he jumped at the chance to do “something bigger than myself.”

“What i’m doing is self gratifying,” Barnes said. “A lot of guys at my age who have walked similar paths have a different story.”

The hemp he uses is grown in Northern Europe, processed in the U.S. and then received by his company in an herbal-concentrate form to disperse into different mediums. His top product contains 900 milligrams of CBD per 30 milliliter bottle, and retails for $105 to $115 for approximately 360 doses.

“We only used industrial hemp plants grown for CBD purposes only, so we can have a presence in every state,” Barnes said. “We offer no false sense of psychoactiveness or illicit use. We wanted to separate ourselves from the stigma.”

Chemotherapy and Cannabis Treatment



Cancer affects almost 40% of the population.

Chemotherapy is a part of many peoples lives, including children. A 2014 study estimated that 15,780 children and teens learned what it means to have cancer that year. That same study found that 1,960 also died from the disease. The remaining 13,820 children had to receive treatment. Most elect for some form of radiation or chemotherapy if surgery isn’t an option.

Anecdotal (evidence based on personal observations and experience) evidence about the effectiveness of cannabis in treating cancer is strong. So strong that there are many studies trying to disprove their claims. Yet the studies consistently (for many types of cancer) show concrete evidence supporting the claims.

It is through these scientific studies that we have learned that cannabis is a powerful phytonutrient and antiseptic. Studies also prove that cannabis is linked to tumor reduction and apoptosis.

Specifically in breast, lung, prostate, colon cancer but a variety of others are under consideration as well.

Thousands of people use cannabis in conjunction with chemotherapy.

Not everyone uses it the same way though. There are a variety of ways canna-consumers incorporate it into their treatment. From Rick Simpson Oil (RSO) to edibles and micro-dosing, the world of cannabis does not require a pipe or patchouli oil. If cannabis is a treatment you decide to use, it doesn’t mean you have to be a stereotypical stoner.

Every cancer journey is unique. After diagnosis, it is up to YOU to determine the path you take. Traditional cancer therapy (chemo, radiation or surgery) is part of standard protocol. But certain cancers may require a combination of methods to properly remove.

Cannabis can play many roles in treatment. Research shows that cannabis is a great adjunct for system relief and healing after invasive procedures. While a typical course of chemotherapy significantly reduces overall immune system function, using cannabis supports quick recovery.

Cannabis provides verifiable symptom relief.

Multiple studies prove that cannabis provides symptom relief of chemotherapy. An Israeli study recently followed 200 traditionally-treated cancer patients. They found that cannabis use led to “significant improvements” in symptoms overall, including the symptoms and immediate side effects of  chemotherapy.

According to the National Cancer Society (NCS), cannabis may help relieve a myriad of side-effects from chemo. These include: nausea and vomiting, loss of appetite, fatigue, itchiness and rash, nerve damage and pain associated with neuropathy. Not to mention their positive effects on generalized pain, and emotional imbalance and mood issues, including anxiety and depression.

In addition to whole plant or natural extracts, the FDA approved Dronabinol to treat “some conditions.” Known by the drug name Marinol, this synthetic cannabinoid treatment is considered less effective than organic cannabis. It also has certain ‘unique’ side effects like neurologic issues and possible seizures.

Cannabis rarely interferes with treatment.

Traditional oncologists may discourage using cannabis while on chemo or radiation treatments. They may claim it could interfere with the treatment and suggest abstaining. It is important to listen to healthcare professionals but treatment is a personal choice.

It is important to remember that thousands of people use cannabis in conjunction with other treatments. Most individuals experience no negative side effects on their treatment. In fact, physicians in medical marijuana states often recommend using cannabis.

In a recent article for Newsweek, Dr. Donald Abrams, Chief of Hematology-oncology at San Francisco General Hospital said “I could write six different prescriptions, all of which may interact with each other or the chemotherapy that the patient has been prescribed,” He followed up by saying “Or I could just recommend trying one medicine.” referring to medical marijuana.

Marijuana acts synergistically with our bodies to promote healing.

The hardest part about chemotherapy is the toll it takes on the body. The majority of people who undergo treatment experience reductions in immune system function. This reduction can last anywhere from months to years after treatment finishes.

A 2016 article in the journal Breast Cancer Research reported that chemotherapy led to long-term changes in the immune system. These changes included lower than average levels of lymphocytes and natural killer cells (also known as NK cells, K cells and killer cells). These are main elements of the immune system and it’s their job to destroy pathogens like cancer cells.

Modern science has revealed that humans have a special element in our immune system. Called the endocannabinoid system, it helps the body achieve homeostasis and balance. Animals without this system (like insects or birds) don’t process THC or other cannabinoids so gain no benefit from using them.

How does the endocannabinoid system interact with cancer?

In addition to providing a boost to recovery and immune system health, cannabinoids interact with the body in many ways. Cannabinoid receptors in the nervous system (called CB1 and CB2 cells) effect everything from hunger to tumor production.

A decrease in endocannabinoids may increase cancer cell tumor production. Researches in a 2008 preclinical trial conducted tests with colon cancer cells at the MD Anderson Cancer Center in Texas.

Their research indicates that cannabinoids have a preventative effect on certain types of cancer.

In addition to reducing cancer cell development, cannabinoids seem to calm the immune system and offer anti-inflammatory properties. This is a key part of healing under any circumstances but is especially important when dealing with cancer. Cannabinoid interactions also show increases in immune-system function.

Oncologists see the benefits of medical marijuana.

Medical marijuana is gaining ground nationally. Oncologists and patients can see the benefits and challenges of integrating cannabis into treatment. Over a fifteen years ago, Harvard conducted a study where 44% of traditional oncologists advised marijuana use. A more recent study found almost half of the physicians surveyed supported medical marijuana.

These studies combine to show that patients have more options than ever. While many hospitals still ban doctors from prescribing/recommending  medical marijuana, that number is decreasing.

Thanks to scientific studies proving the efficacy of medical marijuana and the ceaseless efforts of the community, there are more options than ever.

How Do You Clear a Pot Conviction From Your Record?

By Lee V. Gaines

E ddy, a burly 65-year-old professional musician, walked into a free legal clinic in Los Angeles County one July morning hoping to clear his record. More than three decades ago, he served two years probation for attempting to sell a few gram bags of marijuana, a felony that put the immigrant, a legal U.S. resident with a green card, at greater risk of deportation.
  
Thanks to Proposition 64, the California ballot initiative that legalized the recreational use of marijuana last November, Eddy has a chance for a clean slate. Under one provision of the law, many people with pot-related convictions can apply to have them reduced to lesser offenses or expunged, the legal term for having a case dismissed.

Eddy was one of several dozen people, mostly Latinos and African-Americans, who attended the legal clinic at Chuco’s Justice Center, a graffiti-covered community center in the small city of Inglewood, which borders Los Angeles International Airport. Staffed by volunteers from the national drug reform nonprofit, Drug Policy Alliance, and lawyers from the Los Angeles County public defender’s office, the clinic was one in an ongoing series of events held in recent months to help people get convictions reduced or dismissed.

A little more than a year after the passage of Prop. 64, at least 2,660 petitions have been filed to reduce sentences for people convicted of pot-related offenses. At least another 1,500 petitions have been filed to reclassify old felony marijuana convictions as misdemeanors or to dismiss them altogether, depending on the offense, according to the Judicial Council, the policy-making arm of the state courts.

 
California’s Prop. 64, the California ballot initiative that legalized the recreational use of marijuana last November, built on Prop. 47, which allowed for the reduction of some nonviolent felonies, including theft and some drug charges, to misdemeanors. 
Those figures include self-reported data from a majority of the state’s 58 counties through September, and may be under-reported. According to several public defenders around the state, the Judicial Council’s figures don’t reflect all of the petitions their offices reported filing on behalf of their clients. The Council also doesn’t record the outcome of the requests.

Although the numbers of Prop. 64 applicants so far represent only a portion of the people who have been convicted of pot felonies in recent decades, advocates remain hopeful that as the public learns about the law, more will come forward to have offenses reduced or cleared.

At Chuco’s Justice Center that morning, Eddy was one of about 40 people who received legal assistance, including consultations with paralegals and attorneys, court records checks, and live scan fingerprinting to obtain criminal records from other counties.

Eddy’s conviction was ultimately vacated. Now that his rap sheet is clean, he says he’ll pursue citizenship. “I’m lucky to live in California,” said Eddy, whose father brought him to the U.S. from Central America when he was 9.

He’s right.

Twenty-nine states, the District of Columbia, Puerto Rico, and Guam have legalized medical marijuana, and eight states plus D.C. have sanctioned recreational use. But fewer states have made it possible to clear past marijuana offenses. In the last three years, at least nine states have passed laws addressing expungement of certain marijuana convictions, according to the National Conference of State Legislatures. But no state goes as far as California.

For thousands of Americans, marijuana convictions still bring life-altering consequences, making it difficult to, among other things, find and keep a job, get a professional license or obtain a student loan.

Communities of color have been hit especially hard by the decades-long war on drugs. Studies show a stark racial imbalance in drug enforcement; a 2013 American Civil Liberties Union report concluded that African-Americans were nearly four times more likely to be arrested for marijuana possession than whites, although use of the drug was roughly equal among the races.

Across California, attorneys and drug reform advocates say implementation of Prop. 64 hasn’t been perfect; more resources are needed to process petitions and conduct outreach to people who may be eligible to clear their records and just don’t know it. But overall, they believe the law is an effective tool to undo the collateral damage of felony pot convictions, and they hope it will serve as a model for the rest of the country.

Prop. 64 “gives people the opportunity to recreate themselves and become people instead of statistics,” said Nick Stewart-Oaten, a deputy public defender for Los Angeles County.

C alifornia’s Prop. 64, also known as The Adult Use of Marijuana Act, made it legal for adults to possess and grow small amounts of pot at home, brought some pot-related felonies down to misdemeanors and some misdemeanors down to infractions, and reduced or dismissed prior convictions.

The initiative built on a 2014 law known as Prop. 47, which allowed for the reduction of some nonviolent felonies, including theft and some drug charges, to misdemeanors.

To apply for a reduction under Prop. 64, a petitioner files in the court in which they were convicted, usually with the help of a public defender or a private lawyer. The district attorney’s office reviews each petition, which is then approved or rejected by a judge. The process can take from days to weeks depending on the location.

In some counties, officials didn’t wait for people to come forward to apply for relief under the law; they started the process for them. Soon after Prop. 64 passed, the L.A. County public defender’s office identified people in prison or on parole for marijuana-related offenses and filed petitions for resentencing on their behalf, according to Stewart-Oaten, who said his office has filed 564 such petitions so far.

Similarly, San Diego’s Deputy District Attorney Rachel Solov said her office used their case management system to identify hundreds of eligible people serving a sentence or who were on probation or supervision and then provided the data to the local public defender’s office so that attorneys there could begin filing petitions for those individuals.

“Our primary concern was getting people out of custody who were in custody and shouldn’t be,” Solov said.

Contra Costa County took a similar approach, according to Deputy Public Defender Ellen McDonnell. Her office identified roughly 2,500 people who appeared to be eligible to have convictions reclassified or dismissed on cases dating back 25 years, she said. So far, the office has filed about 80 petitions, mostly for reclassification of old convictions. The office is now engaged in “aggressive community outreach” in the hopes of finding more people who could benefit from the new law, she said.

Identifying everyone eligible for relief under Prop. 64 has been one of the biggest challenges so far, Stewart-Oaten said. 

Original analysis and perspectives from across the spectrum on criminal justice
The public defender’s office doesn’t have the capacity to comb through decades of case files to figure out who may qualify, find their contact information, and persuade them to come into their office to start the paperwork process, he said. The office works with partners like Drug Policy Alliance to help reach people at free legal clinics like the one at Chuco’s Justice Center.

“We recognize it’s not enough, but we are limited in what we can do. We don’t have an advertising budget. A lot of times we are acting on word of mouth,” Stewart-Oaten said.

Alameda County Deputy Public Defender Sue Ra said her office hasn’t received any additional funding for post-conviction relief services, which could help attorneys reach more people and process their petitions faster.

“Somebody needs to do this work, and the public defenders are on the ground actually doing it,” Ra said. “It would be nice to get the support to allow us the resources to complete work quickly so that our clients don’t miss out on employment and other opportunities.”

A s thousands of Californians line up to have their records cleared, Americans with pot convictions in many other states have no such opportunity. Will more states follow California’s lead?

Robert Mikos, a professor at Vanderbilt Law School, isn’t so optimistic.

Many politicians have come around on marijuana legalization, aided by the lure of potential tax revenue and new jobs, Mikos said. Nearly two-thirds of Americans support legalization in a recent poll. But many people appear reluctant to support post-conviction relief for marijuana offenders.

“It’s a tougher sell to say, you know what, these people flouted these rules ... and we ought to wipe those records clean,” said Mikos, an expert on marijuana law.

Even in Washington state, where recreational pot has been legal since 2012, lawmakers have not passed a law that specifically lets people clear old pot offenses. (Those convicted of certain nonviolent crimes, including marijuana-related ones, can already apply to vacate their records but must wait years after completing their sentences; five for some low-level felonies and three for misdemeanors.)

There are exceptions. Although no state has passed a law as sweeping as California’s, several recently have enacted measures that allow pot offenses to be reduced or expunged. In the past year, for example, Colorado began allowing old convictions for misdemeanor marijuana possession or use to be sealed so long as the act wouldn’t be considered illegal today. In Maryland, a new law lets people convicted of marijuana possession apply for expungement four years after the completion of their sentence; the previous wait time was a decade.

A Missouri law set to take effect next year reduces the wait time to expunge nonviolent felonies, including marijuana-related convictions, from 20 to seven years and from 10 to three years for misdemeanors. And in Massachusetts, where recreational pot sales will begin in mid-2018, marijuana possession convictions can now be sealed, which removes them from public view but doesn’t dismiss them. (Lawmakers tossed out a proposed measure to expunge marijuana offenses.)

On the federal level, Mikos points to a bill filed in August by New Jersey Sen. Cory Booker, a Democrat, that could be a blueprint for post-conviction relief on a national scale. The proposal would decriminalize marijuana and expunge federal convictions for possession of the drug.

Booker’s bill would allow the federal government to withhold cash from states with arrest and conviction rates that disproportionately impact the poor and minorities. That approach could be used to pressure states to provide resentencing, reclassification and expungement for marijuana offenses, Mikos said.

However, given Attorney General Jeff Sessions’ pledge to crack down on drug offenders, and his distaste for marijuana legalization in general, any federal measure to decriminalize marijuana may be a pipe dream for reform advocates, Mikos added.

On the state level, even where marijuana use is legal, politicians may never pass laws similar to Prop 64. “Part of that is just that we live in a federal system, and that’s the nature of the game,” Mikos said. “Different states are going to do things differently.”

Community organizers who rallied public support for Prop. 64 last year in California have some advice for people in other states: Do the work yourself.

Ingrid Archie, a legal clinic coordinator with A New Way of Life, a Los Angeles nonprofit that supports formerly incarcerated women, didn’t want to rely on mostly white, wealthy California legislators to pass meaningful criminal justice reforms. That’s why she campaigned for Prop. 64 in the communities impacted the most by marijuana prohibition — people of color and low-income neighborhoods.

Ingrid Archie, at home with her children, was convicted of possession with intent to sell marijuana in 2004. She applied to have her record expunged under Prop. 64.
The African-American mother and grandmother had a personal investment in the issue: Convicted of possession with intent to sell marijuana in 2004, she lost a job, a home and was re-incarcerated after being convicted of child endangerment after she left one of her children in her car while she went into a store to purchase diapers and milk. “It was a trickle of consequence after consequence after consequence all stemming from a marijuana charge,” she said.

Archie contends that grassroots organizing persuaded low-income minorities who may not have supported the idea of legal weed to ultimately back the measure. While Prop. 64 passed with 57 percent of the overall vote, 64 percent of African-Americans backed the ballot initiative compared to 58 percent of white voters.

Archie, who lined up to be one of the first people to apply for expungement under Prop. 64 last year — she started the paperwork a little after midnight on election night last year — hopes organizers and reform advocates in other states follow California’s lead.

If they don’t act, and politicians don’t act, Archie said, millions will continue to suffer the consequences of the war on drugs. Felony records, she said, “ruin people’s lives.”

Friday, 24 November 2017

Cannabis studies overestimate the drug's benefits because participants know they are 'high', expert says

  • Most cannabis studies are double-blind trials, which are used in medical experiments to prevent participants from knowing if they got a placebo
  • In studies of cannabis with THC, participants often know they got the active treatment because they feel its euphoric effect, or 'high'
  • One doctor argues that this means that researchers are overestimating the effectiveness of cannabis to treat medical issues like pain or depression
Some cannabis studies may overstate the substance's benefits because participants know when they are 'high', one scientist argues.
Countless studies have shown that active cannabinoids can effectively treat everything from chronic pain to depression and PTSD - at least according to high people.
Most cannabis studies are double-blind trials, meaning that neither researchers nor participants know which of two groups got a sample containing active cannabinoids, and which got an otherwise identical, inactive substance.
But when feeling 'high' tips off participants in studies using THC - the cannabis chemical the creates that euphoric feeling - the results become skewed, argues one Duke University medical professor.
Cannabis studies may be overestimating its medical benefits because participants know when they are getting 'high,' a Duke University professor argues
Medical marijuana is now legal 29 states in the US.
The legalization movement rode heavily on scientific evidence that cannabinoids - the active portion of the cannabis plant from which marijuana, hashish and hash oil are made - are safe and have have health benefits.
Studies on the therapeutic uses of cannabis have largely followed the gold standard of medical research: double-blind trials.
Double-blind trials are meant to eliminate the bias of participants who don't know if they were given a real treatment or a placebo.
But Duke University professor Dr David Casarett says that cannabis experiments don't control for the high bias.
Most studies on cannabis have participants either smoke or inhale vaporized versions of the plant derivative. 
In these studies, researchers make a control by extracting cannabinoids from cannabis. The resulting product tastes, smells and looks identical, but has none of the psychoactive or physical effects of marijuana or other active forms of cannabis.
In his JAMA Internal Medicine article, Dr Casarett cites one study on cannabis for pain treatment in which all but one of the 15 participants correctly guessed that they'd been given the active form of cannabis.
In another, people that got the real cannabis reported feeling 'high,' 'stoned,' or 'sedated.'
'These participants guess their group assignment in large part because they detect  the psychoactive properties of the active cannabis treatment,' he writes.
In other words, the studies aren't actually all that blind. 

The differences between THC and CBD 

Tetrahydrocannabinol (THC) and cannabidiol (CBD) are both derived from the cannabis plant.
Together, they are part of the cannabinoid group of compounds found in hashish, hash oil, and most strains of marijuana.
THC is the psychoactive compound responsible for the euphoric, 'high' feeling often associated with marijuana.
THC interacts with CB1 receptors in the central nervous system and brain and creates the sensations of euphoria and anxiety.
CBD does not fit these receptors well, and actually decreases the effects of THC, and is not psychoactive.
CBD is thought to help reduce anxiety and inflammation.
When blinding fails, participants are more likely to say they've experienced beneficial effects from an active treatment because they believe that they should.
'These effects should raise substantial concerns over the validity of medical cannabis trials,' Dr Casarett writes. 
The 'high' associated with cannabis comes from THC, one of the chemicals in cannabinoids.
Dr Cassaret only discusses trials that use cannabinoids that still have THC in them, but not all studies do.
In many studies, particularly on cannabis's effects on physical pain, researchers remove THC from the samples they use so that participants are only getting cannabidiol, or CBD.
CBD does not affect the same receptors as THC, so it doesn't create the euphoric 'high' feeling many associate with cannabis.
The effects of CBD are not entirely understood, but it is thought to counteract inflammation in the brain and body.
Dr Casarett suggests that including another psychoactive ingredient in controls, but admits that 'unfortunately, it is not clear what an ideal psychoactive control would be in a cannabis trial.'
Substitutions would have to create euphoria, dry mouth and raise heart rates without providing any of the forms of relief being studied.
Dr Casarett also considers recruiting only people who have never used any form of cannabis and do not know firsthand what its effects feel like.
Other studies, however, have shown that some of the effects of cannabinoids, particularly elevated heart rates are actually most pronounced in people who have never used any form of cannabis.
Regardless, he calls for cannabis studies to acknowledge this limitation.
Otherwise, 'there is a very real risk that physicians and patients will misinterpret the results of these studies and see benefits that do not exist,' he writes.

Cannabis Expert Thinks 35 States Will Legalize Weed By 2020

Nick Givas


The marijuana movement is picking up steam, Krista Whitley, CEO of Nevada-based cannabis company “Altitude Products,” believes and predicts that 35 states will have legal marijuana by the year 2020.
 
“I would hope by 2020 we would have at least 35 thriving regulated cannabis states,” she told The Daily Caller News Foundation. “I am inspired by states like Tennessee and the movements that are happening in traditionally red conservative states, that are seeking out common sense regulated cannabis programs.”
 
“Altitude Products” provides customers in the state of Nevada with marijuana based products from various brands for medical and recreational use. Nevada legalized recreational marijuana by ballot initiative in 2016.
 
“I had not used cannabis until I was 30,” Whitley told TheDCNF in an interview. “I was in a car accident and I was prescribed a bunch of opioids. I felt miserable. I’ve never felt more stoned than when I was on muscle relaxants and pain killers.” A friend recommended she try marijuana as an alternative and she hasn’t looked back since.
 
“I smoked a joint and had the best week of my life. I felt more human. So that was the catalyst for me to start doing some serious research and reexamine some of my own stereotypes,” she added.
 
Despite the progress being made on the state level, the movement to legalized cannabis is being held back by the current White House, Whitley said. She slammed President Donald Trump and Attorney General Jeff Sessions as “ignorant” and said the next administration is more likely to make lasting changes.
 
“If our current president is as entrepreneurial and capitalist as he claims to be, I think it would be common sense for him to deschedule [marijuana]. Unfortunately I don’t think that’s going to happen,” she said. “We continue to fight at the state level, but sadly due to ignorant leadership like Jeff Sessions, I don’t foresee this happening at a federal level. It will take our next administration to get there.”
 
 Those who are against legalization aren’t looking at the issue in a personal way, Whitley said. She thinks if more people shared cannabis success stories, there would be more understanding and less backlash.
 
“When it’s not personal to you and you can’t identify with cannabis users, you end up buying into the stereotypes of the Cheech and Chong movies. What Hollywood has been selling us for generations now,” she said. “I am on the front lines of this and it comes down to personalizing each story. 
 
There’s no shortage of cannabis success stories, especially with the ongoing opioid epidemic.”
 
“Weed is not a gateway drug. It was a bridge to lead people out of their addiction,” she added.
 
Whitley has shared stories from her clientele with marijuana skeptics, and says most people end up changing their minds.
 
“I’ve been able to change a lot of minds. Even the most ardent anti-cannabis people have begun to soften when I’ve shared the personal stories with them of veterans, and children with epilepsy. 
 
You have a harder time taking a hard line with that stuff when you humanize it,” she said. “We need people to come out of the shadows and share testimonials of how cannabis has changed their lives.”
 
Whitley believes legalizing recreational marijuana would also benefit medicinal users by lowering the cost of medical cannabis.
 
“The vast majority of recreational users are truly in some sense medicinal,” she said. “You’ll see discounted taxation, discounted prices. There are significant discounts for medical patients here in the market in Nevada, and I know that’s also true in several other states that have such programs.”

Whitley predicted the pharmaceutical industry will begin transitioning away from narcotics, and embrace cannabis as more states begin to legalize it for recreational use.

“I think the reality is because we are gaining ground around legalization, I think what we’re going to see is a tremendous pivot. All of the sudden these pill pushers are goinng to start to invest in cannabis,” she concluded.

The Mother of Canada’s Marijuana Laws Is a Feminist Hero and a Racist Monster

Emily Murphy, one of Canada’s pioneering feminists, was recently honoured by Justin Trudeau, who left out her dark history.

Joshua Ostroff
Image sources: Wikipedia Commons 

Canada’s yearlong celebration of its history has been consistently sullied by, well, its history, from people pointing out John A. MacDonald’s genocidal tendencies to protests over the statue of Edward Cornwallis, the Halifax founder who placed bounties on Mi’kmaq scalps, including children.

Perhaps the feds were hoping to rectify that by having this year’s Canadian History Week theme be human rights. Which brings us to Canadian historical icon Emily Murphy, leader of the pioneering feminists known as the Famous Five. Prime Minister Justin Trudeau described Murphy and friends just last month as “trailblazers for social justice” who “defined the future of our country.”

This is true. But what JT left out is that Murphy’s influence on Canada was as grotesque as it was great. In fact, Trudeau was elected on the promise of undoing the lesser-known part of her legacy that defined the future of our country’s racist marijuana laws.

Murphy is a perfect example of how history isn’t just written by the victors—it’s also edited by their descendants. Take her 1992 “Heritage Minute,” one of the patriotism-stoking government ads that have attained retro-90s cult status, and which federally-funded Historica Canada proudly reposted on YouTube just last year.

Oscar-nominated actress Kate Nelligan’s in-character monologue explains how Murphy, the first female judge in the British Empire, led a decade-long struggle that eventually saw Canadian women legally recognized as persons in 1929. (Most women, that is. Indigenous women are still waiting in 2017 for the passage of Bill S-3, a court-ordered Indian Act amendment ending the “sex-based inequities” it has enshrined in law since 1876.)

For winning the “Persons Case,” Murphy understandably received a place in history, a plaque in the senate, a brief stint on the $50 bill, an Edmonton park and statues on Parliament Hill and across the country. If you read the (sadly Vin Diesel-free) Famou5.ca website, you’ll learn a lot about Murphy—just not about how she spread racist drug panic across Canada and is widely considered the mother of marijuana prohibition.

That “Heritage Minute” ad did actually mention Murphy’s work as the “author of the Janey Canuck books [and] pioneer in the war against narcotics,” it just left out the context. (It also left out her vocal support for eugenics which helped pass Alberta's Sexual Sterilization Act in 1928. Nearly 5,000 women with mental disabilities were sterilized before it was repealed in 1972.) A TV biography of Murphy made in 1999, also available on YouTube, admits her findings inspired drug legislation into the 1960s but dismisses modern criticism: “It sounds racist now—and it was racist, I guess—but that's what she found as a result of her research."

Murphy’s research was initially published in a series of articles for Maclean’s under the pen name Janey Canuck which, according to the book Crime and Deviance in Canada: Historical Perspectives, were commissioned "for the express purpose of arousing public demands for stricter drug legislation." In 2010, the magazine even published a mea culpa headlined “The Secret Shame of Maclean’s.”

Those articles became the basis for her 1922 best-selling book The Black Candle, alongside original chapters like “Marahuana—A New Menace.” Her conspiracy-theory thesis was that “aliens of colour” had formed a drug syndicate called The Ring to “bring about the downfall of the white race.”

Her lurid prose warned smoking opium would lead to “the amazing phenomenon of an educated gentlewoman, reared in refined atmosphere, consorting with the lowest classes of yellow and black men” and that an addicted woman “doesn't work for anyone but the negro who buys her for the price of opium where with to ‘hit the pipe.’” She also described dealers boasting about “how the yellow race would rule the world” and that “some of the Negroes coming into Canada—and they are no fiddle-faddle fellows either—have similar ideas: and one of their greatest writers has boasted how ultimately they will control the white men.”

Anti-Chinese sentiment in Vancouver had already led to non-medical use of opium being outlawed in 1908, with cocaine and morphine added in 1911. So aside from salaciously vilifying POC even further and spreading hate across the country, what her best-seller added to the national conversation was its warning about cannabis.

Cannabis was almost unknown in Canada at the time, making it easy for Murphy to claim it was poison that would end in “untimely death.” That is, after turning its users into “raving maniacs [who] are liable to kill or indulge in any form of violence to other persons, using the most savage methods of cruelty without, as said before, any sense of moral responsibility.” For publishing this “research,” she nominated herself for a Nobel Prize.

In her book Jailed for Possession, University of Guelph professor Catherine Carstairs has claimed Murphy’s influence was “overstated both by herself and subsequent drug scholars.” But she also acknowledges that “Murphy’s articles did mark a turning point, and her book...brought the Vancouver drug panic to a larger Canadian audience.” Public opinion, of course, is a propellant for such legislation and cannabis wound up added to Canada’s anti-drug law a year after Black Candle’s publication. Canada was the first western country to do so, a full 14 years before the US.

Why does all this matter in 2017? Because it’s important to acknowledge that pot prohibition was born and raised in racism so that we don’t let this problematic past dictate our future.

This week Health Minister Ginette Petitpas Taylor announced that the feds want to know if Canadians support letting people with pot charges into the legal industry. "We have over 500,000 Canadians with minor drug offences on their criminal records,” she said at a November 21 press conference. “We're just asking the question: should these people with a small amount of personal possession, should they be excluded from the market or should we consider them?"

To dig deeper into this question than the minister [publicly] did, a recent Toronto Star report revealed black people with no criminal history are three times more likely than white people to be arrested for possession. Even pot czar (and former police chief) MP Bill Blair admitted in 2016 that “one of the great injustices in this country is the disparity and the disproportionality of the enforcement of these laws and the impact it has on minority communities, Aboriginal communities and those in our most vulnerable neighbourhoods.”

So if people of colour are kept out of the post-prohibition industry because they have criminal records due to race-based enforcement, then that disparity and disproportionality will continue—and Emily Murphy will keep winning the wrong case.